novel coronavirus pneumonia (COVID-19) with mild to moderate anxiety and depression
Conditions
Interventions
Psychological Intervention Group:"Intelligent Psychosomatic Regulation System" Intervention
Sponsors
The First Hospital of Shanxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 75 years old (including threshold), regardless of gender; 2. The patient under isolation observation is diagnosed with mild or common type of 2019-nCoV acute respiratory disease and can cooperate to complete corresponding psychological intervention; 3. The total score of Hamilton depression scale (HAMD17) and Hamilton anxiety scale (HAMA14) at baseline is both at least 7; 4. The patient has sufficient compliance to complete the experiment according to the protocol; 5. The patient and his/her family or guardian sign the informed consent to participate voluntarily in this clinical study.
Exclusion criteria
Exclusion criteria: 1. In the six months before the diagnosis of 2019-nCoV acute respiratory disease, the patient was clearly diagnosed as a psychiatric disorder, including depression, bipolar disorder and so on; 2. Patients with psychotic symptoms; 3. A history of suicide attempt in the 6 months before the study, or a score of more than 3 on item 3 (suicide item) of the HAMD17 scale; 4. The total score of Hamilton depression scale (HAMD17) is more than 24 or the total score of Hamilton anxiety scale (HAMA14)is more than 21 at baseline; 5. The patient is diagnosed with organic mental disorder caused by a systemic disease or a neurological disorder,with a history of severe and unstable physical illness; 6. The patient is undergoing psychotherapy or has received psychotherapy 12 weeks prior to screening; 7. The patient had alcohol abuse within 30 days prior to screening or alcohol or drug dependence within 6 months prior to screening; 8. The patient use antipsychotics, antidepressants, and anti-anxiety drugs within 6 months prior to screening; 9. The researchers believe there are other conditions in the patient that are not suitable for this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the score of Hamilton depression scale;the score of Hamilton anxiety scale;the score of Self-Rating Depression Scale;the score of Self-Rating Anxiety Scale;the score of Athens Insomnia Scale; | — |
Countries
China
Contacts
Public ContactXu Yong
The First Hospital of Shanxi Medical University
Outcome results
None listed